4/A: Charles River Laboratories: Executive James C. Foster Reports Changes in Beneficial Ownership

James C. Foster, Chairman, President, and CEO of Charles River Laboratories, filed an amendment to his Form 4, detailing transactions involving the company's common stock.

Summary

• James C. Foster, Chairman, President, and CEO of Charles River Laboratories, reported changes in his beneficial ownership of the company's stock.
• The report, an amendment to a previous filing, details the acquisition and disposal of common stock.
• On January 29, 2024, Foster acquired 23,741 shares of common stock at $0 and disposed of 10,540 shares at $220.28.
• Following these transactions, Foster directly owns 228,318 shares of common stock.
• He also indirectly owns shares through various trusts and a spousal holding, including 7,580 shares from a 2022 GRAT, 20,000 shares from a 2023 GRAT, and other holdings.
• The acquisition of 23,741 shares reflects shares issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting transactions. The acquisition of shares due to performance goals is mildly positive, while the disposal is mildly negative. Overall, it's a routine filing with no strong positive or negative implications.

Positives

• The acquisition of shares due to performance goals suggests the company met certain targets.

Negatives

• The disposal of 10,540 shares could be interpreted negatively, although it's a relatively small portion of Foster's total holdings.

Risks

• Significant changes in executive stock ownership can sometimes signal uncertainty, although this filing appears routine.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are routinely reported to the SEC. This filing provides transparency into the holdings and transactions of a key executive at Charles River Laboratories.

Comparison to Industry Standards

• Executive compensation packages often include performance-based stock awards, aligning executive interests with shareholder value.
• Form 4 filings are standard practice for reporting changes in beneficial ownership, ensuring transparency and compliance with SEC regulations.
• Comparing Foster's holdings and transactions to those of executives at similar companies (e.g., Envigo (now Inotiv), Laboratory Corporation of America, ICON plc) would provide further context, but that data is not available in this document.

Stakeholder Impact

• The transactions may have a minor impact on shareholders' perception of the company, but the overall effect is likely minimal.

Key Dates